Results 241 to 244 of about 259,945 (244)

PD-L1-negative triple-negative breast cancer exhibited a remarkable response to cadonilimab: a case report. [PDF]

Front Oncol
Chen B, Jia Y, Meng L, Hu N.
europepmc   +1 more source